Compound libraries
Products
EBC main page
Search
Dyes
Impurities
Chemical probes
Contacts us
Pfizer reference compounds
Services
© 2026 Copyright Enamine
Back
Product details:
CAS
1038915-60-4
Purity
95%
Niraparib is an orally active PARP inhibitor. It is used to treat recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer responding to platinum based chemotherapy.
Properties
Name
Niraparib
Smiles
NC(=O)C1=CC=CC2=CN(N=C12)C=3C=CC(=CC3)[C@@H]4CCCNC4
Targets
Please log in to see this information
SDS
((S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide) | 2-[4-((3S)-3-piperidinyl)phenyl]-2H-indazole-7-carboxamide | 2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamide | 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide | MK-4827 | Zejula | niraparib
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$37
2 mg
$39
5 mg
$41
10 mg
$43
15 mg
$45
20 mg
$48
25 mg
$53
30 mg
$56
35 mg
$59
40 mg
$61
45 mg
$64
50 mg
$66
75 mg
$69
100 mg
$POA
Quantity
1
Total amount
$ 41
((S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide) | 2-[4-((3S)-3-piperidinyl)phenyl]-2H-indazole-7-carboxamide | 2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamide | 2-{4-[(3S)-piperidin-3-yl]phenyl}-2H-indazole-7-carboxamide | MK-4827 | Zejula | niraparib
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.